RenovoRx Accounts Payable vs Total Liab Analysis
| RNXT Stock | USD 1.29 0.08 6.61% |
RenovoRx financial indicator trend analysis is much more than just breaking down RenovoRx prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether RenovoRx is a good investment. Please check the relationship between RenovoRx Accounts Payable and its Total Liab accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.
Accounts Payable vs Total Liab
Accounts Payable vs Total Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of RenovoRx Accounts Payable account and Total Liab. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between RenovoRx's Accounts Payable and Total Liab is -0.3. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Liab in the same time period over historical financial statements of RenovoRx, assuming nothing else is changed. The correlation between historical values of RenovoRx's Accounts Payable and Total Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of RenovoRx are associated (or correlated) with its Total Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Liab has no effect on the direction of Accounts Payable i.e., RenovoRx's Accounts Payable and Total Liab go up and down completely randomly.
Correlation Coefficient | -0.3 |
| Relationship Direction | Negative |
| Relationship Strength | Insignificant |
Accounts Payable
An accounting item on the balance sheet that represents RenovoRx obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of RenovoRx are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most indicators from RenovoRx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into RenovoRx current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.At this time, RenovoRx's Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 44.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 3.5 M in 2024.
| 2021 | 2023 | 2024 (projected) | Depreciation And Amortization | 9K | 5.4K | 5.1K | Interest Income | 57K | 111K | 64.4K |
RenovoRx fundamental ratios Correlations
Click cells to compare fundamentals
RenovoRx Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RenovoRx Stock Analysis
When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.